APGE Apogee Therapeutics Inc.

Price (delayed)

$88.91

Market cap

$6.7B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.33

Enterprise value

$6.26B

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 89
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 6

We are a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with ...

Highlights
The quick ratio has soared by 107% YoY and by 23% from the previous quarter
APGE's equity has surged by 86% year-on-year and by 39% since the previous quarter
APGE's net income is down by 34% year-on-year and by 7% since the previous quarter
The company's EPS fell by 20% YoY and by 2.6% QoQ

Key stats

What are the main financial stats of APGE

APGE stock price

How has the Apogee Therapeutics stock price performed over time
Intraday
5.61%
1 week
14.25%
1 month
6.42%
1 year
143.59%
YTD
17.79%
QTD
5.63%

Financial performance

How have Apogee Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$305.27M
Net income
-$274.62M
Gross margin
N/A
Net margin
N/A
APGE's net income is down by 34% year-on-year and by 7% since the previous quarter
Apogee Therapeutics's operating income has decreased by 26% YoY and by 7% QoQ

Price vs fundamentals

How does APGE's price correlate with its fundamentals

Growth

What is Apogee Therapeutics's growth rate over time

Valuation

What is Apogee Therapeutics stock price valuation
P/E
N/A
P/B
4.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 20% YoY and by 2.6% QoQ
APGE's equity has surged by 86% year-on-year and by 39% since the previous quarter

Efficiency

How efficient is Apogee Therapeutics business performance
The company's return on invested capital fell by 17% YoY but it rose by 2.3% QoQ
Apogee Therapeutics's ROA has decreased by 16% YoY but it has increased by 10% from the previous quarter
APGE's return on equity is down by 15% year-on-year but it is up by 11% since the previous quarter

Dividends

What is APGE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APGE.

Financial health

How did Apogee Therapeutics financials performed over time
The quick ratio has soared by 107% YoY and by 23% from the previous quarter
The current ratio has surged by 106% year-on-year and by 23% since the previous quarter
The debt is 99% less than the equity
APGE's equity has surged by 86% year-on-year and by 39% since the previous quarter
APGE's debt to equity has plunged by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.